Linezolid

Kathryn Dzintars, Pharm.D., BCPS, Paul A. Pham, Pharm.D.
Pediatric Dosing Author: Alice Jenh Hsu, PharmD, BCPS, AQ-ID

INDICATIONS

FDA

Pneumonia, hospital-acquired caused by MRSA, MSSA, and S. pneumoniae.
- Generally reserved for MRSA.
Community acquired pneumonia caused by S. pneumoniae and MSSA.
- Not a preferred agent for CAP.
Infections due to vancomycin-resistant Enterococcus faecium (VRE), with or without concurrent bacteremia.
Complicated and uncomplicated skin and skin structure infection including diabetic foot ulcers (without osteomyelitis).

NON-FDA APPROVED USES

Vascular catheter associated sepsis
Surgical wound infections
Furuncle/carbuncle
Cellulitis/erysipelas
Osteomyelitis, acute (second-line agent)
Osteomyelitis, chronic (second-line agent)
Septic arthritis, community-acquired (limited data)
Hardware associated septic arthritis (limited data)
Tuberculosis
Non-tubercular mycobacteria
Nocardia

There's more to see -- the rest of this topic is available only to subscribers.

© 2000–2025 Unbound Medicine, Inc. All rights reserved

All content is protected by copyright and may not be used for AI model training or other unauthorized purposes.